3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
14
Lung Neoplasms
13
Urinary Bladder Neoplasms
11
Ovarian Neoplasms
8
Non-Muscle Invasive Bladder Neoplasms
6
Neoplasm Metastasis
5
Colorectal Neoplasms
5
Cholangiocarcinoma
5
Lymphoma, Large B-Cell, Diffuse
4
Fallopian Tube Neoplasms
4
Breast Neoplasms
4
Biliary Tract Neoplasms
4
Triple Negative Breast Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Nasopharyngeal Carcinoma
3
Melanoma
3
Recurrence
2
Rectal Neoplasms
2
Osteosarcoma
2
Lymphoma, Follicular
2
Gallbladder Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Transitional Cell
2
Bile Duct Neoplasms
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Urologic Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Interventions
enzalutamide
16
Magnetic Resonance Spectroscopy
16
apalutamide
15
Prednisone
12
Androgen Antagonists
12
Abiraterone Acetate
12
Specimen Handling
11
darolutamide
7
abiraterone
7
Radiotherapy
7
Pluvicto
6
Nivolumab
6
Docetaxel
6
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
6
cabazitaxel
5
Radiosurgery
5
Lutetium-177
5
Biopsy
5
radium Ra 223 dichloride
4
cabozantinib
4
bicalutamide
4
atezolizumab
4
Standard of Care
4
Lutetium
4
olaparib
3
gallium 68 PSMA-11
3
Watchful Waiting
3
Surveys and Questionnaires
3
Radiotherapy, Intensity-Modulated
3
Fulvestrant
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Gemcitabine
×
30 days
×
Clear all
No trials found.